Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1754-1611
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform ; volume:10 ; number:1 ; day:30 ; month:9 ; year:2016 ; pages:1-13 ; date:12.2016
Journal of biological engineering ; 10, Heft 1 (30.9.2016), 1-13, 12.2016
- Creator
- Contributor
-
Wurzel, Joel
Hoffmann, Kyra
Ladner, Tobias
Büchs, Jochen
Meinel, Lorenz
Lühmann, Tessa
SpringerLink (Online service)
- DOI
-
10.1186/s13036-016-0031-6
- URN
-
urn:nbn:de:1111-201610319091
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wandrey, Georg Benjamin
- Wurzel, Joel
- Hoffmann, Kyra
- Ladner, Tobias
- Büchs, Jochen
- Meinel, Lorenz
- Lühmann, Tessa
- SpringerLink (Online service)
Other Objects (12)
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Pharmaceutically relevant protein-protein interactions for controlled drug delivery
Monitoring enzyme activity by using mass-encoded peptides and multiplexed detection
Ionic liquids of active pharmaceutical ingredients: A novel platform addressing solubility challenges of poorly water soluble drugs
Therapeutic systems for Insulin-like growth factor-1
Adding new functions to insulin-like growth factor-I (IGF-I) via genetic codon expansion
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Lowering lattice forces in drug substance crystals to improve dissolution and solubility
Bioinspired drug delivery of interleukin-4
Drug delivery of therapeutic gases – strategies for controlled and local delivery of carbon monoxide
Bioresponsive delivery of anticatabolic and anabolic agents for muscle regeneration using bioinspired strategies
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Pharmaceutically relevant protein-protein interactions for controlled drug delivery
Monitoring enzyme activity by using mass-encoded peptides and multiplexed detection
Ionic liquids of active pharmaceutical ingredients: A novel platform addressing solubility challenges of poorly water soluble drugs
Therapeutic systems for Insulin-like growth factor-1
Adding new functions to insulin-like growth factor-I (IGF-I) via genetic codon expansion
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Lowering lattice forces in drug substance crystals to improve dissolution and solubility
Bioinspired drug delivery of interleukin-4
Drug delivery of therapeutic gases – strategies for controlled and local delivery of carbon monoxide
Bioresponsive delivery of anticatabolic and anabolic agents for muscle regeneration using bioinspired strategies
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Pharmaceutically relevant protein-protein interactions for controlled drug delivery
Monitoring enzyme activity by using mass-encoded peptides and multiplexed detection
Ionic liquids of active pharmaceutical ingredients: A novel platform addressing solubility challenges of poorly water soluble drugs
Therapeutic systems for Insulin-like growth factor-1
Adding new functions to insulin-like growth factor-I (IGF-I) via genetic codon expansion
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Lowering lattice forces in drug substance crystals to improve dissolution and solubility
Bioinspired drug delivery of interleukin-4
Drug delivery of therapeutic gases – strategies for controlled and local delivery of carbon monoxide